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Genomic imprinting is an epigenetic feature characterized by parent-specific monoallelic 
gene expression. The aim of this study was to compare the DNA methylation status 
of imprinted genes and imprinting control regions (ICRs), harboring differentially 
methylated regions (DMRs) in a comprehensive panel of 18 somatic tissues. The 
germline DMRs analyzed were divided into ubiquitously imprinted and placenta-
specific DMRs, which show identical and different methylation imprints in adult 
somatic and placental tissues, respectively. We showed that imprinted genes and ICR 
DMRs maintain methylation patterns characterized by intermediate methylation levels 
in somatic tissues, which are pronounced in a specific region of the promoter area, 
located 200–1500 bp from the transcription start site. This intermediate methylation 
is concordant with gene expression from a single unmethylated allele and silencing 
of a reciprocal parental allele through DNA methylation. The only exceptions were 
seen for ICR DMRs of placenta-specific imprinted genes, which showed low levels of 
methylation, suggesting that these genes escape parent-specific epigenetic regulation 
in somatic tissues.
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Genomic imprinting is an epigenetic gene-
marking phenomenon that is mostly estab-
lished in germline and results in monoallelic 
gene expression according to parental ori-
gin [1,2]. The process of genomic imprinting 
is widely associated with fetal growth and 
maturation as parent-specific gene activity has 
predominantly been found in placental tis-
sue. According to the most widely accepted 
‘parental conflict hypothesis’, the paternally 
expressed genes force maternal resources to 
support the ongoing pregnancy, while the 
maternally expressed genes tend to distribute 
the resources equally among all her offspring. 
Thus, imprinting creates the balance between 
opposing parental interests and ensures the 
best reproductive outcome for both genders.
In addition to prenatal expression, postna-
tal gene imprinting may also occur, mainly in 
the brain [3], likely influencing personal and 
parenting behavioral, cognitive and emo-
tional characteristics. Furthermore, some 
studies have also emphasized the importance 
of parental inheritance of a risk allele as a 
possible epigenetic cause of common diseases 
such as obesity [4] and Type II diabetes [5]. 
This explains why the focus of research for 
imprinted genes has shifted from placenta 
to postnatal somatic tissues, aiming to pro-
vide more detailed biological data and evolu-
tionary explanations to parent-specific gene 
dosage in pre- and postnatal origin of disease.
Previous studies have shown that many 
imprinted genes are present in clusters [6,7], 
as in mouse, for instance, the proportion of 
clustered genes exceeds 80% of total number 
of imprinted genes [8]. The clustered orga-
nization allows cis-regulation of monoallelic 
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expression via imprinted control regions (ICRs) [6,9,10], 
which possess parental-specific DNA methylation 
and/or histone modifications [11,12]. These regions have 
been validated in a series of mouse knock-out experi-
ments and have been shown to occur in human epi-
genetic diseases, revealing the unique contribution of 
the respective genes [9,10]. Every ICR harbors at least 
one differentially methylated region (DMR); the CpG 
island, which exhibits parent-specific DNA methyla-
tion. A sole ICR DMR can regulate the expression of 
the nearest single imprinted gene or the entire gene 
cluster.
Imprinted DMRs are classified into two groups – pri-
mary DMRs, also called germline DMRs and second-
ary, also referred to as somatic DMRs. The germline 
DMRs acquire their methylation status during game-
togenesis, are stably maintained through epigenetic 
reprogramming at oocyte-to-embryo transition, and 
survive during somatic aging [13–15]. Somatic DMRs, in 
contrast, acquire their methylation status postfertiliza-
tion and are regulated by nearby germline ICR DMRs 
in a hierarchical manner [16–18]. The germline DMRs 
are further subdivided into ubiquitously imprinted and 
placenta-specific imprinted genes, which show identi-
cal and different methylation imprints in adult somatic 
and placental tissues, respectively [19].
As imprinted genes have methylation marks only 
on one parental allele, they show intermediate meth-
ylation levels at ICR DMRs [16–17,19–20]. Whether this 
intermediate methylation pattern is maintained in 
somatic tissues throughout the life course, includ-
ing growth, development and aging, remains to be 
answered. A recent study investigated this question 
and demonstrated stable DNA methylation imprints 
for all germline DMRs, which maintained an inter-
mediate methylation level between 35 and 65% in 
all adult somatic tissues, independent of gene expres-
sion [21]. However, the conclusions of this study are 
somewhat tentative because results were obtained for 
only a subset of imprinted genes for a restricted num-
ber of CpGs. This limitation prompted us to investi-
gate epigenome-wide ICR DMRs on a wider panel of 
adult somatic tissues.
Recent developments in array and sequencing-based 
methylation profiling methods have significantly 
improved our understanding of the global epigenetic 
regulation of the entire genome and individual genes, 
and have offered novel tools for studies of imprinted 
genes and their DMRs. In these analyses, the meth-
ylation status of CpG sites are expressed as beta 
(β)-values, representing the methylation levels of the 
CpG locus using the ratio of methylated and unmeth-
ylated alleles [22]. The assumption of more frequent 
CpG sites with an intermediate methylation level in 
imprinted genes led us to postulate that the propor-
tion of ‘intermediate-β-value CpG sites’ in imprinted 
genes exceeds that of nonimprinted genes, across the 
entire span of genes, even in adult somatic tissues. 
We also tested a previously proposed hypothesis that 
known germline ICR DMRs are persistently inherited 
across many adult somatic tissues by retaining inter-
mediate methylation levels. Furthermore, we expected 
minimal variance of methylation levels, as expressed by 
β-values, for imprinted genes as they have more probes 
with an intermediate methylation level, representing 
an equal ratio of unmethylated and methylated alleles 
of the expressed and silenced alleles, respectively. In 
contrast, for nonimprinted genes, we presumed greater 
variance in β-values, as a more random and mixed dis-
tribution of the unmethylated and methylated CpG 
loci is expected, depending on the tissues examined.
Therefore, the aim of the current study was to ana-
lyze the methylation status of the imprinted genes and 
their regulative ICR DMRs in somatic tissues. In order 
to avoid interindividual variability between tissue sam-
ples, a panel of 17 tissues from four autopsy patients 
was used for DNA separation, bisulfite treatment and 
subsequent epigenome analysis using the Illumina 
Infinium HumanMethylation450 BeadChip, covering 
486,428 probes. In addition, the tissue panel was com-
plemented with whole-blood samples from 97 healthy 
adults from Estonian Genome Centre of University of 
Tartu (EGCUT).
In our study, we focused on the 76 previously estab-
lished imprinted genes and 59 germline ICR DMRs, 
as extracted from a search of available databases and 
literature. The methylation pattern of imprinted genes 
in somatic tissues was compared with that of nonim-
printed genes, in order to highlight whether the gene 
methylation signature of imprinted and nonimprinted 
genes could be distinguished in adult somatic tissues. 
Furthermore, the location of intermediately methyl-
ated CpG sites in imprinted and nonimprinted genes 
was compared will reveal possible critical regulatory 
regions for gene activity. Finally, we analyzed the 
methylation status of all known germline-imprinted 
DMRs in somatic tissues to assess whether the meth-
ylation status of these critical genome regions is stably 
maintained in diverse somatic tissues obtained from 
the same individual.
Results
Distribution of CpG methylation for imprinted 
& nonimprinted genes
We compared the distribution of CpG methylation in 
autopsy tissue panel in 76 imprinted genes from a data-
base search (Supplementary Table 1) and 20,515 nonim-
printed genes captured by the Illumina array. We esti-
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mated the proportions of different CpG methylation 
ranges, as categorized by β-values, and performed a 
one-tailed chi-squared test with one degree of freedom, 
to determine which region best characterizes ‘inter-
mediate methylation status’ (Supplementary Table 2). 
Probes over the entire length of a gene were included 
in this analysis. According to the Illumina annotation, 
30.9% of the probes are in promoter areas (13.0 and 
17.9% are within 1–200 and 200–1500 nucleotides 
upstream from the transcription start site, TSS200 and 
TSS1500, respectively), 4.3 and 15.0% are in 3′UTRs 
and 5′UTRs, respectively, 7.8% in the first exons and 
42.0% in gene bodies. Based on these data, the biggest 
difference in methylation levels between imprinted and 
nonimprinted genes was found for the ‘intermediately 
methylated’ CpGs with the  corresponding β-value of 
0.5–0.7 (p = 9.33 × 10-187).
Next, we visualized the methylation patterns of all 
CpGs of imprinted genes, also incorporating well-
defined ICR DMRs [19]. When we compared the den-
sity plot of methylation levels of all probes across all 
17 autopsy tissues between imprinted (Figure 1A) and 
nonimprinted (Figure 1B) genes, we observed many 
more intermediately methylated probes with β-values 
of 0.5–0.7 for imprinted genes (25.5%) than for non-
imprinted genes (10.0%). Also, the number of probes 
with smaller β-values (<0.5), indicating the subset of 
CpG sites with low methylation, was less for imprinted 
(28.2%) than for nonimprinted genes (48.1%). The 
number of probes with higher methylation levels 
(>0.7) showed the smallest difference for imprinted 
and nonimprinted genes (46.2 and 41.9%, respec-
tively). According to the performed tests, all results 
were significantly different (p = 2.76 × 10-145) for the 
three categories of β-values (<0.5, 0.5–0.7 and >0.7) 
between imprinted and nonimprinted genes.
Similar results were also observed for DNA methyla-
tion of blood samples from healthy adults. The propor-
tion of probes with low methylation levels (β-values 
of <0.5) was 34.9% for imprinted genes and 48.9% 
for nonimprinted genes (p = 3.93 × 10-25), while the 
proportion of probes with high methylation levels 
(β-values >0.7) was lower for nonimprinted genes 
compared with imprinted genes (39.1 and 44.0%, 
respectively; p = 0.0079). Intermediately methylated 
probes demonstrated the biggest difference for these 
two groups of genes (21.2% for imprinted and 12.0% 
for nonimprinted genes, p = 1.76 × 10-121).
Equality of variances
We used Levene’s test (levenes.test function in R, 
version 3.2.1) to compare the variance of β-values of 
imprinted and nonimprinted genes that were captured 
by the methylation array. We compared 76 previously 
validated imprinted genes with 76 randomly selected 
nonimprinted genes for each of the 17 postmortem tis-
sues analyzed, iterating the procedure 100-times. We 
also performed the same procedure using whole-blood 
samples from healthy adults. Supplementary Table 3 
presents the average variance of imprinted genes, aver-
age variance of 76 randomly selected nonimprinted 
genes and average p-value from Levene’s test across 
all comparisons. We found that imprinted genes have 
smaller variance in β-values than nonimprinted genes 
(e.g., p = 2.31 × 10-14 for brain tissue and p = 4.22 × 10-12 
for nerve tissue). We also observed a similar distribu-
tion of methylated probes for blood samples (p = 8.71 
× 10-12), corroborating evidence that imprinted genes 
show less variability in methylation across a broad 
range of tissue types.
The location of intermediately methylated 
probes
For all genes captured by the methylation array, we 
counted the proportion of intermediately methylated 
probes with β-values in the range 0.5–0.7 for differ-
ent locations within a gene. The array provides access 
to six regions of a gene: promoter, 5′UTR, the first 
exon, gene body and 3′UTR, while the promoter 
area is further divided into two regions, 200 and 
200–1500 nucleotides from TSS of a gene (TSS200 
and TSS1500, respectively). We performed a one-
tailed chi-squared test to check whether imprinted 
genes, excluding imprinted DMRs [19], contain 
more intermediately methylated probes at specific 
locations when compared with nonimprinted genes 
(Figure 2). We discovered that the TSS1500 pro-
moter area of imprinted genes contains 22.8% more 
0.5–0.7 β-value probes than nonimprinted genes 
(p = 6.57 × 10-5). Also the 3′UTR area of imprinted 
genes has 34.2% less 0.5–0.7 β-value probes than 
nonimprinted genes (p = 6.2 × 10-13). The differ-
ences in the TSS200, 5′UTR, the first exon and gene 
body were only 7.9, 7.3, 2.2 and 5.7% (p = 0.2128, 
p = 0.2578, p = 0.7929 and p = 0.338), respectively, 
and all insignificant after multiple correction. Thus, 
imprinted genes show a higher percentage of interme-
diately methylated probes with β-values in the range 
0.5–0.7 in an extended promoter region, spanning 
1500 bp from the transcription start site.
Analysis of germline ICR DMRs
We used the list of known germline ICR DMRs [19] 
to test whether the methylation status of these critical 
genome regions is stably maintained during the forma-
tion of multiple types of somatic tissues. From 67 avail-
able imprinted DMRs we were unable to normalize 
two regions for the ZFAT and LIN28B genes, while six 
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Figure 1. Visualization of beta-density and methylation level (vertical axis – beta-density (maximum value of 10) and horizontal 
axis – methylation level) for imprinted (A) and nonimprinted (B) genes, captured by methylation array. Positive and negative controls 
are shown by blue and red lines, respectively. Each tissue is shown by a gray line. Imprinted genes have an increased number of 
intermediately methylated probes with beta-value in 0.5–0.7 range, if compared with nonimprinted genes, as shown in gray boxes.
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DMRs had no Infinium probes after performing qual-
ity control. A total of 59 remaining ICR DMRs were 
thus retained for further analysis, which were divided 
into two groups – ubiquitously imprinted (n = 45) and 
placenta-specific imprinted genes (n = 14), as recently 
suggested [19] (Figure 3). All ubiquitously imprinted 
DMRs demonstrated remarkable stability of β-values, 
varying from 49 to 77%, across all 18 somatic tissues 
tested. In contrast, placenta-specific DMRs presented 
low β -values, ranging from 10 to 20% in the somatic 
tissues tested, except for two genes (GPR1-AS and 
MIR512). These two DMRs were found to have inter-
mediate methylation levels of 55 and 67%, respectively 
(Supplementary Table 4), as we observed for ubiqui-
tously imprinted genes. However, visualization dem-
onstrated that only GPR1-AS had the pattern specific 
to ubiquitously imprinted DMRs, while MIR512 had a 
unique pattern that was characterized by an increased 
number of highly methylated probes and a small num-
ber of intermediately and lowly methylated probes 
(Figure 3).
Discussion
The aim of this study was to compare the DNA meth-
ylation of imprinted genes, their ICR DMRs and non-
imprinted genes, in a comprehensive panel of somatic 
tissues. For this analysis, a unique panel of 17 tissues, 
each obtained from four autopsy patients was used. 
In addition, the tissue panel was complemented by 97 
whole-blood samples obtained from healthy volunteers 
of the same North-European origin. DNA from all 
somatic tissue samples was analyzed using the Illu-
mina Infinium HumanMethylation450 BeadChip, 
providing quantitative methylation data at the single 
CpG-site level for 486,428 probes. Our results dem-
onstrated that the general pattern of methylation over-
laps between all 18 tissue samples, providing assurance 
that blood samples are a valuable source of DNA for 
imprinting studies.
The present study is based on analysis of imprinted 
genes, which were selected based on available data-
bases and verified by a ‘PubMed search’, providing 
clear evidence of parent-specific monoallelic expres-
sion (Supplementary Table 1). For the majority of the 
76 imprinted genes, there is overwhelming evidence of 
monoallelic expression of either of the parental allele 
in placental and embryonal somatic tissues, and/or in 
pre- and postnatal brain. In contrast, data to investi-
gate the methylation and expression of imprinted genes 
in adult somatic tissues are particularly scarce, and are 
limited to a few reports using a restricted supply of 
tissues from the same individuals [19,21]. The wide tis-
sue panel obtained from the same autopsy patients is a 
major advantage of our study, eliminating the effect of 
interindividual heterogeneity in epigenetic regulation 
of imprinted genes on study outcome.
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Figure 2. Visualization of probes with beta-value in range of 0.5–0.7 for imprinted genes and nonimprinted 
genes. Promoter region TSS1500 has the highest ratio of intermediately methylated probes in imprinted genes, 
while the smallest difference was detected in TSS200, 5′UTR, the first exon and gene body regions. The asterisks 
define the differences of 22.8 and 34.2% for TSS1500 and 3′UTR, respectively, being the only significant results 
for this analysis. The TSS1500 promoter area of imprinted genes contains 22.8% more 0.5–0.7 β-value probes than 
nonimprinted genes (p = 6.57 × 10-5). The 3′UTR area of imprinted genes has 34.2% less 0.5–0.7 β-value probes 
than nonimprinted genes (p = 6.2 × 10-13). The differences in the TSS200, 5′UTR, the first exon and gene body were 
only 7.9, 7.3, 2.2 and 5.7% (p = 0.2128, p = 0.2578, p = 0.7929, and p = 0.338), respectively; being insignificant after 
multiple correction. 
TSS: Transcription start site.
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Gene imprinting is primarily achieved by the silenc-
ing of one parental allele via methylation of CpG-rich 
islands located at ICRs. Therefore, more intermedi-
ately methylated CpG sites are expected in imprinted 
genes and their ICR DMRs, which correspond to 
gene expression from the single unmethylated allele 
and silencing of the reciprocal parental allele through 
DNA methylation. However, the question of whether 
imprinted genes also retain the intermediately methyl-
ated DNA pattern in somatic tissues of adult humans 
has, so far, remained unclear.
We observed that imprinted genes possess more CpG 
loci with intermediate β-values of 0.5–0.7, along the 
entire length of a gene, in the extensive panel of somatic 
tissues tested. Our panel covered a wide range of tissues, 
formed from all three germ layers during embryogen-
esis: mesodermal (e.g., adipose tissue, bone and lymph 
nodes), endodermal (e.g., gastric mucosa and tonsils), 
ectodermal (e.g., coronary artery) and even neuroec-
todermal (e.g., ischiatic nerve and medulla oblongata) 
origin. Furthermore, a similar prevalence of intermedi-
ately methylated CpG sites was observed in DNA from 
blood, which is one of the most thoroughly studied tis-
sues in the human body. Data from 17 postmortem tis-
sues provided convincing evidence that imprinted genes 
more often retain (25.5% of all CpG sites) intermedi-
ately methylated CpGs when compared with nonim-
printed genes, for which the respective share was only 
10%. These results suggest that parental influence on 
gene expression is not abolished in somatic tissues of 
adult organisms, and explains the possible association 
between parent-of-origin effects and risk of common 
diseases. Parental-specific effects are gaining promi-
nence, as previous studies have highlighted that paren-
tal ancestry of inherited alleles plays an important role 
in the development of complex  diseases, like obesity [4] 
and Type II diabetes [5].
We also hypothesized that the variance of β-values in 
imprinted genes is smaller than in nonimprinted genes 
because they have more intermediately methylated CpG 
probes. This uniformity is likely contrasted by non-
imprinted genes, for which expression is highly tissue 
dependent, resulting in a more stochastic pattern and 
co-existence of methylated and unmethylated alleles 
794 Epigenomics (2016) 8(6)
Figure 3. Visualized methylation patterns across 17 human somatic tissues for known germline ICR DMRs. Positive and negative 
controls are shown by blue and red lines, respectively. Each tissue is shown by a gray line, whereas the mean of all tissues is shown by 
black line. The pattern specific for ubiquitously imprinted ICR DMRs is associated with increased number of intermediately methylated 
probes. While the placenta-specific ICR DMRs are associated with dominance of lowly methylated probes, except for GPR1-AS and 
MIR-512 genes for which unique patterns were observed (as explained in the text).
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of the same gene. Indeed, our results seem to support 
this view, as we observed smaller variance in β-values 
for imprinted genes than for nonimprinted genes, as 
shown by Levene’s test to compare 76 imprinted genes 
with 76 nonimprinted genes. In order to strengthen 
this result, the comparison was performed 100-times, 
with different sets of randomly selected nonimprinted 
genes in each permutation. The results of this analysis 
also suggested that the number of imprinted genes is 
relatively low, as 100 comparisons of randomly selected 
www.futuremedicine.com 795future science group
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nonimprinted genes showed comparable variances for 
β-values. In conclusion, these results together provide 
strong evidence that genomic imprinting is main-
tained across 18 tissues. Unlike many previous studies 
of imprinted genes, which were limited to a restricted 
number of tissues, such as placenta or fetal tissues, 
our study demonstrates clear stability in methylation 
of the tested imprinted genes in somatic tissues, and 
highlights blood as an excellent candidate tissue for the 
study and discovery of novel imprinted genes.
We also studied the locations of intermediately meth-
ylated CpG sites with β-values in the range of 0.5–0.7, 
and found that imprinted genes show a higher concen-
tration in this range in a specific region of promoter 
area located 200–1500 bp from the transcription start 
site. This finding is strongly supported by our recent 
study [23], in which DNA methylome profiling was 
used to identify tissue-specific differentially methylated 
regions. In this study, we used the same comprehen-
sive tissue panel from autopsy patients and compared 
the detected methylation patterns with publicly avail-
able gene expression data. We were motivated to exploit 
publicly available gene expression data because the tis-
sue samples were obtained from autopsy patients, which 
inevitably led to delay in tissue collection and 4–8 h 
autolysis time. Although the gene expression patterns 
before death and postmortem are largely comparable, 
death may still induce significant changes in a relatively 
large number of genes [24,25]. Consequently, we compared 
our DNA methylome data with that of gene expression 
from public databases, and observed a clear inverse cor-
relation between promoter methylation within CpG 
islands and gene expression [23]. This finding clearly sup-
ports the notion that epigenetic gene regulation is medi-
ated via selective promoter methylation. In the current 
study, we demonstrated that the highest proportion of 
intermediately methylated CpG sites is located in pro-
moter regions of imprinted genes, providing a convinc-
ing explanation as to why only a single parental allele is 
expressed, rather than a biallelic mode of activity.
The relationship between low and high promoter 
methylation with gene expression and silencing, respec-
tively, is not a new idea itself [26–29]. Nevertheless, to our 
knowledge, the current study is the first to provide com-
pelling evidence that imprinted genes maintain an inter-
mediately methylated status in somatic tissues of adult 
humans, even when the ICR DMR-related CpGs were 
excluded. However, whether these ontogenetically con-
served epigenetic variations also impact parental-depen-
dent monoallelic expression of those genes in somatic 
tissues remains an open question. In order to fully 
understand the parental effect on gene expression, the 
unequivocal ascertainment of the parental origin of the 
transcribed allele(s) is required. For example, genome 
imprinting can be studied by applying whole-transcrip-
tome RNA sequencing of tissue and genotyping of cod-
ing DNA variants in family trios, as we recently used 
for placenta [30]. In this study, parental and child blood 
DNA genotypes were analyzed by exome SNP geno-
typing microarrays, mapping the inheritance and esti-
mating the abundance of parental expressed alleles in 
placental tissue. Imprinted genes showed predominant 
expression from one of the parental alleles, as demon-
strated by the SNP content of sequenced transcripts. 
However, the use of a similar approach to study imprint-
ing in somatic tissues raises more complex ethical and 
practical challenges, mostly because of the difficulties in 
obtaining the  tissue  samples from family trios.
The current study strongly supports the recently 
raised hypothesis in the seminal paper of Court et al. [19] 
that substantiates the distribution of germline ICR 
DMRs between ubiquitously imprinted and placenta-
specific imprinted genes. Placenta-specific imprinted 
DMRs exist solely in placental tissue and are absent 
in somatic tissues, including leukocytes, brain, liver, 
 kidney and muscle [19]. Our results, based on a substan-
tially extended list of somatic tissues, corroborated the 
view of DMRs as divided into two groups, and showed 
that ubiquitously imprinted DMRs demonstrate an 
intermediate level of methylation in all somatic tissues. 
It is likely that this group of genes maintains a simi-
lar intermediate methylation of germline imprinted 
DMRs in all embryonal and extra-embryonal (pla-
cental) tissues during prenatal development, as well 
in most of somatic tissues through adult development 
and aging. In contrast, placenta-specific imprinted 
DMRs exhibited, according to our study, low levels of 
methylation in somatic tissues. It is well known that 
high levels of gene expression are often associated with 
low levels of methylation [28,31], leading us to the idea 
genes found to be imprinted in placental tissue could 
escape monoallelic expression in adult somatic tissues. 
Indeed, genes such as GLIS3, DNMT1 and LIN28B 
support this idea, being regulated by placenta-specific 
ICRs and monoallelically expressed in placental tis-
sue only [15,32]. We found only two exceptions among 
the placenta-specific imprinted genes – GPR1-AS and 
MIR512, which showed an intermediate methylation 
pattern characteristic to ubiquitously imprinted genes. 
The placenta only imprinting of these two genes has 
also been found by other researchers [33,34].
Remarkably, in all placenta-specific DMRs, only 
the maternal allele is methylated [19]. Intriguingly, 
placenta-specific imprinted genes do not inherit meth-
ylation from the gametes. So, in that sense, by strict 
definition, the DMRs unique to placenta cannot be 
classified as germline-originating parental epigenetic 
marks. However, these epigenetic loci provide evidence 
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for a heritable epigenetic mechanism, which is indepen-
dent from DNA methylation. Therefore, it has been 
speculated that during gamete formation, the parental 
alleles of these genes retain some nonequivalences that 
are not associated with DNA methylation, but rather 
with histone modifications, justifying their classifica-
tion as germline DMRs. As a consequence, the mater-
nally marked alleles will obtain the methylation signals 
in early embryonal development, when the trophoblast 
cells are formed, yielding the exclusive imprinted gene 
methylation profile for placental tissue [19].
In conclusion, we demonstrate that the majority of 
imprinted genes and ICR DMRs maintain intermediate 
methylation status in the extended panel of adult somatic 
tissues obtained from the same individuals investigated 
in this study. This intermediately methylated pattern is 
more pronounced in specific regions of promoter areas 
of imprinted genes when compared with nonimprinted 
genes. However, the remarkable exception was seen for 
placenta-specific imprinted genes, which showed low 
levels of methylation, suggesting that these genes likely 
escape parental-specific epigenetic regulation in adult 
somatic tissues. Although our study has extended knowl-
edge of gene imprinting in somatic tissues, future stud-
ies are required to provide deeper understanding about 
the regulation of imprinted genes in somatic  tissues 
throughout the complete human lifespan.
Materials & methods
Sample collection
Seventeen different somatic tissue samples used in the 
current study were obtained from four autopsy patients 
– one female (BM419) and three males (KA522, 
KT538 and SJ600). They were 60, 53, 40 and 54 years 
of age, respectively, at the time of death. Their causes 
of death were either cerebellar hemorrhage (BM419 
and SJ600) or myocardial infarction with acute car-
diovascular insufficiency (KA522 and KT538), being 
the only severe disease for these patients. Between 4 
and 8 h passed between the death of each subject and 
the collection of tissue samples.
Samples were collected from the following locations: 
abdominal and subcutaneous adipose tissue; coronary 
and splenic artery; bone; yellow and red bone marrow; 
gastric mucosa; joint cartilage; lymph node; tonsils; 
bladder; gallbladder; abdominal and thoracic aorta; 
medulla oblongata and ischiatic nerve. All 17 tissues 
were obtained from every study subject, except in the 
case of one individual (BM419) for whom the yel-
low bone marrow and joint cartilage tissues were not 
available. All samples were snap-frozen in liquid nitro-
gen and stored at -80°C prior to analysis. The tissue 
samples were collected at the Pathology Centre within 
the North Estonia Medical Centre, Estonia. More 
information about the subjects for tissue-panel study is 
 provided in our previous studies [23,35–36].
Whole blood samples were obtained from 97 healthy 
adult individuals (N
male
 = 48 and N
female
 = 49) selected 
from EGCUT. All subjects were older than 18 years, 
with a mean age of 52.7 years, and gave  written 
informed consent for participation in the study.
The study was carried out with the approval of the 
Research Ethics Committee of the University of Tartu.
DNA extraction & methylation array analysis
DNA was extracted from 25 mg tissue samples using 
the NucleoSpin® Tissue kit (Macherey-Nagel GmbH, 
Düren, Germany). DNA from whole blood samples was 
extracted by the salting-out method using 10 M ammo-
nium acetate. DNA was precipitated in isopropanol, 
washed in 70% ethanol and finally resuspended in 1× TE 
buffer. The purity and concentrations of the DNA sam-
ples were measured by spectrophotometer (NanoDrop® 
ND1000; Thermo Fisher Scientific, Inc., MA, USA).
Negative and positive controls for unmethylated and 
methylated DNAs, respectively, were also represented 
in this study. For ‘unmethylated control DNA’, the 
DNA from subcutaneous adipose tissue was amplified 
using the GenomiPhi kit (GE Healthcare, NJ, USA), 
while for ‘methylated control DNA’ the universal 
methylated human DNA standard (Zymo Research 
Orange, CA, USA) was used. From each sample, 600 
ng of genomic DNA was bisulfite modified using the 
EZ DNA Methylation kit (Zymo Research Orange) 
according to the manufacturer’s recommendations for 
the Illumina Infinium Assay.
After purification, 4 μl of each bisulfite-converted 
DNA sample and controls (total of 165 samples) was 
used for hybridization on the Infinium Human Meth-
ylation 450 BeadChip, following the Illumina Infin-
ium HD Methylation protocol. The original IDAT 
files were extracted from the HiScan scanner. We also 
processed two technical (the same DNA was ana-
lyzed twice) and two biological (the extraction from 
the same tissue was performed twice and both of the 
DNAs were analyzed) replicates. The Pearson correla-
tion coefficients (PCCs) were >0.99 for all the repli-
cates, confirming a good level of reproducibility for the 
array analysis.
Methylation normalization
Data processing and quality control analyses were per-
formed using the Bioconductor package minfi [37]. Pre-
normalized raw data was used to convert the intensities 
from the red and the green channels into methylated 
(M) and unmethylated (U) signals. β-values for each 
CpG probe were calculated according to Illumina’s 
recommendations using [β = M/(M+U+100)].
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The difference in the distribution of β-values for 
type I and type II probes was corrected using SWAN 
(Subset-quantile Within Array Normalization) nor-
malization [38]. Detection p-values were obtained for 
every CpG probe in every sample. Failed positions were 
defined as signal levels lower than background from 
both methylated and unmethylated channels. Probes 
with detectable methylation level in <5% of samples 
(detection p-value <0.01) were excluded. Also, CpG 
sites on X and Y chromosomes, cross-reactive probes 
and SNPs inside the probe body or at the nucleotide 
extension were discarded, which left 353,094 probes 
for further analysis.
CpG sites location mapping
An Illumina Infinium HumanMethylation450 Bead-
Chip contains more than 485,000 methylation sites, 
covering 21,231 out of 21,474 UCSC RefGenes, with 
an average of 17 CpG sites per gene. In order to achieve 
a comprehensive assessment of gene region methyla-
tion, each gene was split into six regions. CpG sites 
are distributed across the promoter, 5′UTR, the first 
exon, gene body and 3′UTR regions. Promoter regions 
were further divided into two mutually exclusive bins 
of 1–200 bp and 200–1500 bp blocks upstream of the 
transcription start site. Each CpG site for validated 
genes was mapped to its exact location in the genome 
using the Illumina annotation file, build 37.
Equality of variances
In the case of gene imprinting, we expected more inter-
mediately methylated probes, and therefore mid-range 
β-values, which should lead to smaller variance of 
β-values among these probes. We used Levene’s test to 
compare the equality of variances of probes’ β-values 
between imprinted and nonimprinted genes.
The list of human imprinted genes & ICR DMRs
We used the ‘Catalogue of Parent of Origin Effects 
Imprinted Genes and Related Effects’ database [39] 
and ‘Geneimprint’ catalogue [40] as an open scientific 
source to identify the list of human imprinted genes, 
with all references provided in Supplementary Table 1. 
Also we used the ‘PubMed search’ to find articles 
related to these imprinted genes and to verify that all 
our imprinted genes are indeed shown to be imprinted 
in humans. Also, highly isoform-dependent tran-
scripts were excluded from this list. In addition, genes 
that have previously been found to be imprinted 
in model organisms and were only predicted to 
be imprinted in humans based on the conserved 
sequences between two species were also excluded 
from this list. In total, we were left with 76 known 
human imprinted genes for downstream analyses. In 
all analyses, we compared these genes with the rest 
of 20,515 nonimprinted genes, captured by Illumina 
array. The list of germline ICR DMRs was obtained 
from the previous study [19].
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